In summary, our data indicate that in IPF patients, increased circulating BAFF levels correlate with reduced BAFFR expression and that increased circulating TGF-β levels are associated with decreased BCR signaling. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.